(Q39790686)

14 September 2017

title

Exacerbation history is associated with medication and appointment adherence in MS. (English)

1 reference

14 September 2017

Laura M Hancock

1

1 reference

14 September 2017

Jared M Bruce

series ordinal

2

1 reference

14 September 2017

Sharon G Lynch

series ordinal

3

1 reference

14 September 2017

language of work or name

1 reference

23 January 2011

1 reference

Journal of Behavioral Medicine

14 September 2017

published in

1 reference

14 September 2017

volume

34

1 reference

14 September 2017

issue

5

1 reference

14 September 2017

page(s)

330-338

1 reference

Revised estimate of the prevalence of multiple sclerosis in the united states

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Clinical correlates of generalized worry in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Pain and affective memory biases interact to predict depressive symptoms in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Adherence to interferon-beta treatment and results of therapy switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Disease-modifying agents in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Pediatric appointment keeping: improving adherence in a primary care allergy clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Disease-modifying therapy in multiple sclerosis: update and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Adaptation of a motivational interviewing intervention to improve antidepressant adherence among Latinos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Immunomodulatory treatment strategies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

The impact of stressful life events on risk of relapse in women with multiple sclerosis: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

No-show rates in the vascular laboratory: analysis and possible solutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Relationship between adherence to study and clinic visits in systemic lupus erythematosus patients: data from the LUMINA cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Multiple sclerosis: side effects of interferon beta therapy and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10865-011-9316-X

Motivational interviewing for adherence problems in cystic fibrosis

21 January 2018

1 reference

12 December 2020

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

1 reference

12 December 2020

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence

1 reference

12 December 2020

Brief report: Predictors of optimal HIV appointment adherence in minority youth: a prospective study

1 reference

12 December 2020

Family behavior, adaptation, and treatment adherence of pediatric nephrology patients

1 reference

12 December 2020

Effectiveness of reminder systems on appointment adherence rates

1 reference

12 December 2020

A descriptive study of missed appointments: families' perceptions of barriers to care

1 reference

12 December 2020

Motivational Interviewing to promote self-awareness and engagement in rehabilitation following acquired brain injury: A conceptual review.

1 reference

12 December 2020

Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Time and money: effects of no-shows at a family practice residency clinic.

1 reference

12 December 2020

Automated telephone reminder messages can assist electronic diabetes care

1 reference

12 December 2020

Early treatment of multiple sclerosis to prevent neurologic damage

1 reference

12 December 2020

Kurtzke scales revisited: the application of psychometric methods to clinical intuition

1 reference

12 December 2020

Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence

1 reference

12 December 2020

Predictors of adherence to glatiramer acetate therapy in individuals with self-reported progressive forms of multiple sclerosis.

1 reference

12 December 2020

Mild visual acuity disturbances are associated with performance on tests of complex visual attention in MS

1 reference

12 December 2020

Depression in multiple sclerosis: review and theoretical proposal

1 reference

12 December 2020

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. Jacobs LD,*(1) Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW, and the CHAMPS Study Group. N

1 reference

12 December 2020

10.1007/S10865-011-9316-X

Identifiers

DOI

1 reference

release_mms25wgjpzd75czqktrjxvzsn4

14 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mms25wgjpzd75czqktrjxvzsn4

24 November 2022

mapped directly with Wikidata item

1 reference